kr588.40
0.93% today
Copenhagen, Nov 27, 10:45 am CET
ISIN
DK0060448595
Symbol
COLO B

Coloplast A/S B Stock price

kr583.00
-19.40 3.22% 1M
-55.00 8.62% 6M
-203.20 25.85% YTD
-311.20 34.80% 1Y
-294.60 33.57% 3Y
-322.00 35.58% 5Y
+23.00 4.11% 10Y
+516.18 772.45% 20Y
Copenhagen, Closing price Wed, Nov 26 2025
-4.20 0.72%
ISIN
DK0060448595
Symbol
COLO B

New AI Insights on Coloplast A/S B Insights AI Insights on Coloplast A/S B

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
kr132.1b
Enterprise Value
kr153.8b
Net debt
kr21.7b
Cash
kr947.0m
Shares outstanding
225.4m
Valuation (TTM | estimate)
P/E
36.1 | 22.5
P/S
4.7 | 4.4
EV/Sales
5.5 | 5.1
EV/FCF
29.5
P/B
8.2
Dividends
DPS
kr22.00
Yield 1Y | 5Y
3.8% | 2.0%
Growth 1Y | 5Y
4.8% | 4.1%
Payout 1Y | 3Y
136.4% | 79.0%
Increased
2 Years
Financials (TTM | estimate)
Revenue
kr27.9b | kr29.9b
EBITDA
kr9.1b | kr9.7b
EBIT
kr7.7b | kr8.3b
Net Income
kr3.6b | kr5.8b
Free Cash Flow
kr5.2b
Growth (TTM | estimate)
Revenue
3.1% | 7.2%
EBITDA
6.4% | 14.7%
EBIT
5.3% | 8.4%
Net Income
-28.0% | 60.4%
Free Cash Flow
268.5%
Margin (TTM | estimate)
Gross
68.0%
EBITDA
32.7% | 32.6%
EBIT
27.5%
Net
13.0% | 19.5%
Free Cash Flow
18.7%
Financial Health
Equity Ratio
33.3%
Return on Equity
22.6%
ROCE
18.3%
ROIC
10.4%
Debt/Equity
1.4
More
EPS
kr16.1
FCF per Share
kr23.2
Short interest
-
Employees
17k
Rev per Employee
kr1.7m
Show more

Is Coloplast A/S B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Coloplast A/S B Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Coloplast A/S B forecast:

8x Buy
31%
16x Hold
62%
2x Sell
8%

Analyst Opinions

26 Analysts have issued a Coloplast A/S B forecast:

Buy
31%
Hold
62%
Sell
8%

Financial data from Coloplast A/S B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
27,874 27,874
3% 3%
100%
- Direct Costs 8,929 8,929
2% 2%
32%
18,945 18,945
4% 4%
68%
- Selling and Administrative Expenses 10,420 10,420
3% 3%
37%
- Research and Development Expense 946 946
4% 4%
3%
9,123 9,123
6% 6%
33%
- Depreciation and Amortization 1,453 1,453
13% 13%
5%
EBIT (Operating Income) EBIT 7,670 7,670
5% 5%
28%
Net Profit 3,636 3,636
28% 28%
13%

In millions DKK.

Don't miss a Thing! We will send you all news about Coloplast A/S B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Head office Denmark
CEO Lars Rasmussen
Employees 16,628
Founded 1957
Website www.coloplast.dk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today